28-Mar-2024
No headlines found.
Globe Newswire (Wed, 13-Mar 7:00 AM ET)
ADC Therapeutics to Participate in the Guggenheim 5th Annual Healthy Altitudes Summit
Globe Newswire (Wed, 6-Mar 7:15 AM ET)
Globe Newswire (Wed, 6-Mar 7:00 AM ET)
Globe Newswire (Tue, 5-Mar 5:45 PM ET)
ADC Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference
Globe Newswire (Tue, 27-Feb 7:00 AM ET)
ADC Therapeutics Regains Compliance with NYSE Continued Listing Standards
Globe Newswire (Thu, 4-Jan 7:15 AM ET)
ADC Therapeutics Provides Business Updates
Globe Newswire (Thu, 4-Jan 7:00 AM ET)
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.
Adc Therapeutics SA Common Shares trades on the NYSE stock market under the symbol ADCT.
As of March 28, 2024, ADCT stock price climbed to $4.49 with 967,021 million shares trading.
ADCT has a beta of 1.65, meaning it tends to be more sensitive to market movements. ADCT has a correlation of 0.02 to the broad based SPY ETF.
ADCT has a market cap of $370.56 million. This is considered a Small Cap stock.
Last quarter Adc Therapeutics SA Common Shares reported $17 million in Revenue and -$.97 earnings per share. This beat revenue expectation by $1 million and missed earnings estimates by -$.47.
In the last 3 years, ADCT stock traded as high as $32.00 and as low as $.36.
ADCT has outperformed the market in the last year with a price return of +126.8% while the SPY ETF gained +33.6%. ADCT has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +161.0% and +15.1%, respectively, while the SPY returned +10.1% and +1.7%, respectively.
ADCT support price is $3.89 and resistance is $4.51 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ADCT stock will trade within this expected range on the day.